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Method: We performed a prospective observational study which aimed to
describe all patients over 75 years hospitalized in a cardiology department. For
each patient we collected cause of hospitalisation, medical and cardiovascular
history. We compared patients with and without previous history of AF (“AF
group” versus “sinus group”).
Results: Among 1050 patients admitted during an inclusion period of
4 months, 357 patients were older than 75 years: 150 in the “AF group” and
207 in the “sinus group”. AF was paroxysmal, persistent and permanent
respectively in 21%, 30%, and 48% of cases.
Table – Main data
Conclusion: Patients over 75 years of age accounted for 34% of patients
admitted in our cardiology department and 42% of them had a history of atrial
fibrillation.
AF patients had more frequently valvular disease, thyroid dysfunction,
which are comorbidities associated with AF but also more strokes, dementia
and hospitalization for heart failure which may be consequences of AF.
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The risk of atrial fibrillation (AF) in patients with paroxysmal supraventric-
ular tachycardia (SVT) is well-known. AF is a cause of embolic event and a
risk of stroke in patients with SVT can be expected. The purpose of the study
was to assess the prevalence of unexplained stroke in patients presenting with
SVT and to look for the risk factors.
Methods: Electrophysiological study (EPS) was performed in 1379 patients
without anterograde conduction through accessory pathway (AP) for SVT.
Clinical and electrophysiological data were collected.
Results: Stroke was noted in 38 patients (group I) (prevalence 2.8%).
1341 patients had no stroke (group II). 1) Clinical data: Group I was older
than group II (62±13 vs 49±19 years) (p<0.0002). Associated heart disease
(14/38, 37% vs 139/1341, 10%)(p<0.0001), AF history (4/38, 10.5%, 32/1341,
2%, p<0.002) were more frequent in group I than in group II. Male gender
was similar in both groups. 2) Electrophysiological data: SVT mechanism
was similar: AV re-entrant tachycardia in a concealed AP was noted in 4
group I patients (10.5%) and 247 group II patients (18%)(NS). Signs of atrial
vulnerability were as frequent in both groups. 3) Follow-up (mean 3±3 years):
Adverse events (AE) occurred in 102 patients: 3 group II patients presented a
stroke; AF occurred in 8 group I patients (21%), 62 group II patients
(5%)(p<0.0001); 3 group I patients (8%), 26 group II patients (2%) died from
cardiovascular death (p<0.01). SVT ablation was performed in 65 of
102 patients (64%) with AE (AF or death), 790 of 1277 patients without AE
(62%)(NS). Age (p=0.001), prior AF (p=0.001) were the 2 independent risk
factors of stroke at multivariate analysis stroke. Adjusted on age, heart disease
was not significantly associated with stroke.
Conclusions: Unexplained stroke was a rare event in patients with paro-
xysmal SVT (2.8%). Old age, and AF history were the only independent sig-
nificant factors associated with the history of stroke in these patients. They
had a risk of severe adverse events during the follow-up as spontaneous AF
(21%) or death (8%). SVT ablation did not reduce the risk of new stroke,
spontaneous AF or death.
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Introduction: Catheter ablation has emerged as a realistic therapeutic
option for symptomatic atrial fibrillation (AF). Young patients with AF are
often more symptomatic and long-term taking medication is very demanding
for their daily life. The aim of our study is to describe the safety and the long-
term effectiveness of catheter ablation of AF in patients under 30 years of age.
Methods and results: Twenty five consecutive patients < 30 years old
(mean age: 26±3; 16-29) with paroxysmal (13 pts, 52%) or persistent AF
(12 pts, 48%, AF duration 40±24 months) underwent catheter ablation of
symptomatic atrial fibrillation refractory to at least one antiarrythmic drug
(AAD), in our center. Only 3 patients had structural heart disease (hypertro-
phic cardiomyopathy). Patients were hospitalized and monitored at 3, 6 and 12
months, every 6 months thereafter and at the end of the follow up. Mean radio
frequency duration was 51±29 min (39±14 for PAF and 65±40 for PsAF) for
total procedure time of 176±91 min (128±55 for PAF and 224±100 for PsAF)
and a fluoroscopic time of 52±33 min (38±20 for PAF and 62±36 for PsAF).
In all procedures, no major complication occurred. After a mean follow up of
54 months ± 29; 21/25 (84%) patients remained arrhythmia-free (92% for
PAF and 76% for PsAF) after a mean of 1.6 procedure per patient. 19 of the
21 arrhythmia free patients were also AAD free. Only 3 patients of these
21 patients were treated with warfarin.
Conclusion: These finding suggest that catheter ablation of AF in patients
under 30 years of age is safe, with good clinical long term outcome. Catheter
ablation of AF can be first-line therapy in young people.
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TOTAL
=357
AF group 
=150 (42%)
Sinus group
=207(58%)
p
Age 82±13 83±13 81±11 0.03 
Men 186 75 (50) 106 (51.2) 0.9
HTA 178 (50) 76 (50.7) 102 (49.5) 0.9
Diabetes 86 (24.1) 35 (23.3) 51 (24.7) 0.1
Dyslipemia 93 (26.1) 35 (23.3) 58 (28.2) 0.3
Ischemic heart 
disease
13 (38.8) 55 (36.7) 83 (40.3) 0.1
Respiratory failure 26 (7.28) 13 (8.6) 13 (6.28) 0.4
Valvular heart disease 38 (10.5) 20 (13.3) 18 (8.73) 0.04
Pulmonary embolism 20 (5.6) 13 (8.6) 7 (3.3) 0.02
AVC 39 (10.9) 23 (15.3) 16 (7.7) 0,01
Thyroid disease 32 (8.9) 18 (12) 14 (6.7) 0.03
Dementia 23 (6.5) 13 (8.7) 10 (4.9) 0.1
Alcoholism 11 (3) 10 (6.7) 1 (0.48) 0.01
Main cause of
hospitalisation
   
Cardiac heart failure 111 (31) 67 (44.7) 44 (21.4) <0.001
Acute coronary 
syndrome
67 (19) 11 (7.3) 56 (26.6) <0.001 
